Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_CROHN_2NDLINE
Extra metadata
List of similar endpoints to
Second line medication for Crohns disease
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13437 | 8356 | 5081 |
| Unadjusted prevalence (%) | 5.17 | 5.69 | 4.49 |
| Mean age at first event (years) | 50.99 | 50.25 | 52.21 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.04 | 2.60 [2.03, 3.33] | 3.0e-14 | 662 |
| 15 years | 0.02 | 2.96 [2.38, 3.68] | 1.3e-22 | 620 |
| 5 years | 0.00 | 4.21 [3.43, 5.17] | 9.7e-43 | 253 |
| 1 year | 0.00 | 3.31 [2.31, 4.75] | 7.5e-11 | 39 |
Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohns disease
GWS hits: 13
before Second line medication for Crohns disease
after Second line medication for Crohns disease
Loading survival analyses plot
Loading survival analyses table